SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-012140
Filing Date
2023-07-24
Accepted
2023-07-24 15:53:16
Documents
12
Period of Report
2023-07-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20230720x8k.htm   iXBRL 8-K 35147
  Complete submission text file 0001558370-23-012140.txt   159279

Data Files

Seq Description Document Type Size
2 EX-101.SCH krbp-20230720.xsd EX-101.SCH 3129
3 EX-101.LAB krbp-20230720_lab.xml EX-101.LAB 16578
4 EX-101.PRE krbp-20230720_pre.xml EX-101.PRE 10531
6 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20230720x8k_htm.xml XML 5027
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 231105004
SIC: 2836 Biological Products, (No Diagnostic Substances)